1-5 of 5
Hongwei Xu, MD, MS
Close
Sort by
Journal Articles

NEK2 Regulates Immature B Cell Development and GC Formation in NEK2 Transgenic Mouse

Wen Zhou, PhD, Xiao He, He Wang, Mohamed E Salama, M.D., Xia Jiliang, Hongwei Xu, MD, MS, Maurizio Zangari, MD, Guido J. Tricot, MD, PhD, Fenghuang Zhan, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 257.
https://doi.org/10.1182/blood.V120.21.257.257
Published: 2012
Journal Articles

Inhibition of RARĪ±2 or Its Downstream Signaling Pathways Decreases Drug Resistance in Myeloma

Guido J. Tricot, MD, PhD, Ye Yang, PhD, Fang Xiao, PhD, Maurizio Zangari, MD, Hongwei Xu, MD, MS, Fenghuang Zhan, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 989.
https://doi.org/10.1182/blood.V118.21.989.989
Published: 2011
Journal Articles

ALDH1 Activity Identifies Chemotherapy-Resistant Multiple Myeloma Stem Cells

Fenghuang Zhan, MD, PhD, Wen Zhou, PhD, Maurizio Zangari, MD, Hongwei Xu, MD, MS, Guido J. Tricot, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 990.
https://doi.org/10.1182/blood.V118.21.990.990
Published: 2011
Journal Articles

The Effect of ICAM-1 Antibody Therapy in the SCID-Hu Mouse Model Using Primary Myeloma Cells

Guido J. Tricot, MD, PhD, Ming Zeng, Ye Yang, PhD, Maurizio Zangari, MD, Hongwei Xu, MD, MS, Fenghuang Zhan, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 2914.
https://doi.org/10.1182/blood.V118.21.2914.2914
Published: 2011
Journal Articles

High Expression of NEK2 Induces Drug Resistance by Inhibiting Premature Senescence Through Activation of the PI3K/Akt Pathway in Myeloma and Other Cancers,

Fenghuang Zhan, MD, PhD, Fang Xiao, PhD, Maurizio Zangari, MD, Hongwei Xu, MD, MS, Guido J. Tricot, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 3923.
https://doi.org/10.1182/blood.V118.21.3923.3923
Published: 2011